Abstract & Background Patients with metastatic non–small-cell lung cancer have a substantial symptom burden and may receive aggressive care at the end of life. We examined the effect ...

To the Editor: In the Special Article on outcome reporting in industry-sponsored trials of gabapentin for off-label use, Vedula et al. (Nov. 12 issue)1 claim to have identified unacceptable ...

As a teenager, I had the unfortunate but ultimately career-shaping experience of watching my maternal grandmother decline from Alzheimer's disease. She resided in a nursing home, where her final ...